Patient Monitoring Devices Market

The report "Patient Monitoring Devices Market By Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031" The patient monitoring devices market is projected to reach USD 76.11 billion by 2031, up from USD 55.60 billion in 2026, at a CAGR of 6.4%.

Browse 250 market data Tables and 100 Figures spread through 300 Pages and in-depth TOC on "Patient Monitoring Devices Market By Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/patient-healthcare-monitoring-systems-devices-market-678.html

The growing aging population, which requires continuous monitoring and long-term healthcare management, is playing a crucial role in driving the patient monitoring devices market. Elderly individuals are more susceptible to chronic conditions such as cardiovascular diseases, diabetes, respiratory disorders, and neurological conditions, increasing the need for continuous health monitoring and timely clinical intervention. Patient monitoring devices, including continuous glucose monitors (CGMs), wearable ECG systems, pulse oximeters, and remote monitoring platforms, enable real-time health tracking and improve disease management across hospital and home-care settings. The growing shift toward preventive and home-based care, supported by telemedicine and digital health technologies, is further accelerating adoption. Additionally, the increasing healthcare focus on patient-centric care and the reduction of hospital burden continue to strengthen global demand for advanced, connected patient monitoring solutions.

Blood glucose monitoring devices accounted for the largest share of the patient monitoring devices market in 2025.

The widespread adoption of blood glucose monitoring devices across both developed and emerging regions significantly contributes to their leading market share. The increasing prevalence of diabetes and growing need for continuous disease management have accelerated demand for glucose monitoring solutions worldwide. Continuous glucose monitoring (CGM) systems and self-monitoring blood glucose devices provide real-time glucose insights, enabling better treatment decisions and improved patient outcomes. Additionally, increasing awareness of preventive healthcare and the growing preference for home-based monitoring solutions are supporting broader adoption. Technological advancements such as wearable CGM devices, smartphone connectivity, and cloud-based data integration further enhance patient convenience and treatment adherence. Furthermore, favorable reimbursement support and strong product innovation continue to strengthen the segment’s position, reinforcing its dominance in the global patient monitoring devices market.

Hospitals & clinics accounted for the majority share of the patient monitoring devices market in 2025.

The increasing prevalence of chronic diseases, rising hospital admissions, and growing demand for continuous patient surveillance are key factors driving the dominance of hospitals & clinics in the patient monitoring devices market. Hospitals and clinics remain the primary settings for monitoring patients with cardiovascular diseases, diabetes, respiratory disorders, and critical care conditions that require real-time tracking of vital parameters. General wards, intensive care units (ICUs), and emergency & trauma centers increasingly rely on multiparameter monitors, glucose monitoring systems, cardiac monitoring devices, and other advanced monitoring technologies. Additionally, the expansion of healthcare infrastructure, growing patient volumes, and rising investments in connected healthcare systems continue to strengthen device adoption. As healthcare facilities increasingly prioritize early diagnosis, continuous monitoring, and improved patient outcomes, procurement and utilization of patient monitoring devices continue to rise, reinforcing the segment’s leading market position.

Asia Pacific is projected to exhibit the highest growth rate in the patient monitoring devices market during the forecast period.

Asia Pacific has a large and rapidly aging population, along with a rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions, particularly in countries such as China, India, and Japan. The increasing disease burden and growing patient pool are significantly driving demand for continuous monitoring solutions across healthcare settings. Additionally, improvements in healthcare infrastructure, expanded access to medical services, and increased healthcare expenditures are accelerating the adoption of advanced patient monitoring technologies. The growing penetration of wearable devices, remote patient monitoring solutions, and digital healthcare platforms further supports market expansion. As healthcare systems across the region continue strengthening critical care and home-based healthcare capabilities, the demand for patient monitoring devices is expected to increase substantially, supporting the region’s high growth trajectory.

Key Market Players:

Key players in this market are adopting various organic and inorganic growth strategies, including product launches, agreements, collaborations, acquisitions, and expansions. Prominent players in this market include Medtronic Plc. (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED

Don’t miss out on business opportunities in Patient Monitoring Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]